Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Hypertension Reports
Erschienen in: Current Hypertension Reports 11/2023

25.08.2023 | Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review

verfasst von: Marva Foster, Anna Etchin, Charlene Pope, Christine W. Hartmann, Oluwabunmi Emidio, Hayden B. Bosworth

Erschienen in: Current Hypertension Reports | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To conduct a scoping review of articles which examined the impact of COVID-19 on HTN and HTN medication adherence among underrepresented racial/ethnic minorities.

Recent Findings

Seven studies were included in this review and impact of COVID-19 was examined at 4 levels: patient, provider, health system and society. The results indicated that patient level factors, such as high unemployment and inequitable access to telemedicine due to society factors- lack of access to high-speed Internet and variation in the offering of telehealth by health systems, were most impactful on adherence. Additionally, provider level clinical inertia may have further impacted adherence to HTN medication.

Summary

Our review showed that the COVID-19 pandemic did not introduce new barriers but exacerbated preexisting barriers. Ongoing efforts are needed to change policies at the state and local levels to dismantle inequities in underrepresented communities to ensure access to health care with telemedicine to promote health equity.
Literatur
1.
Benjamin EJ, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146–603.PubMedPubMedCentralCrossRef
2.
Lor M, et al. Association Between Health Literacy and Medication Adherence Among Hispanics with Hypertension. J Racial Ethn Health Disparities. 2019;6(3):517–24.PubMedPubMedCentralCrossRef
3.
Deere BP, Ferdinand KC. Hypertension and race/ethnicity. Current Opinion in Cardiology. 2020;35(4):342–50.PubMedCrossRef
4.
5.
6.
Virani SS, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254–743.PubMedCrossRef
7.
Lane D, et al. Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. Hypertension. 2022;79(1):12–23.PubMedCrossRef
8.
Cramer JA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.PubMedCrossRef
9.
10.
McQuaid EL, Landier W. Cultural Issues in Medication Adherence: Disparities and Directions. J Gen Intern Med. 2018;33(2):200–6.PubMedCrossRef
11.
World Health, O. Adherence to long-term therapies : evidence for action / [edited by Eduardo Sabaté]. Geneva: World Health Organization; 2003.
12.
13.
14.
Laffin LJ, et al. Rise in Blood Pressure Observed Among US Adults During the COVID-19 Pandemic. Circulation. 2022;145(3):235–7.PubMedCrossRef
15.
Lopez L, Hart LH, Katz MH. Racial and Ethnic Health Disparities Related to COVID-19. JAMA, 2021;325(8):719–20.
16.
Xie Z, et al. Racial and ethnic disparities in medication adherence among privately insured patients in the United States. PloS one. 2019;14(2):e0212117–e0212117.PubMedPubMedCentralCrossRef
17.
Benner JS, et al. Long-term persistence in use of statin therapy in elderly patients. Jama. 2002;288(4):455–61.PubMedCrossRef
18.
Adams AS, et al. Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013;173(1):54–61.PubMedPubMedCentralCrossRef
19.
Egan BM, et al. Association of Baseline Adherence to Antihypertensive Medications With Adherence After Shelter-in-Place Guidance for COVID-19 Among US Adults. JAMA Network Open. 2022;5(12):e2247787–e2247787.PubMedPubMedCentralCrossRef
20.
Choudhry NK, et al. Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association. Hypertension. 2022;79(1):e1–14.PubMedCrossRef
21.
Arksey H, O’Malley L. Scoping Studies: Towards a Methodological Framework. Int J Soc Res Methodol. 2005;8(1):19–32.CrossRef
22.
Tricco AC, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
23.
24.
Alexander GC, et al. Use and Content of Primary Care Office-Based vs Telemedicine Care Visits During the COVID-19 Pandemic in the US. JAMA Network Open. 2020;3(10):e2021476–e2021476.PubMedPubMedCentralCrossRef
25.
James MK, Kishore M, Lee S-W. Demographic and Socioeconomic Characteristics of COVID-19 Patients Treated in the Emergency Department of a New York City Hospital. J Community Health. 2021;46(4):711–8.PubMedCrossRef
26.
Gotanda H, et al. Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations. Hypertension. 2022;79(12):2733–42.PubMedCrossRef
27.
Heinert SW, Riggs R, Prendergast H. Emergency Department Management of Hypertension in the Context of COVID-19. Curr Hypertens Rep. 2022;24(2):37–43.PubMedPubMedCentralCrossRef
28.
Patel P, et al. Optimizing the Potential for Telehealth in Cardiovascular Care (in the Era of COVID-19): Time Will Tell. Am J Med. 2021;134(8):945–51.PubMedPubMedCentralCrossRef
29.
McCarthy CP, et al. Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020;26:100504–100504.PubMedPubMedCentralCrossRef
30.
Bress AP, et al. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. J Am Heart Assoc. 2021;10(11):e020997–e020997.PubMedPubMedCentralCrossRef
31.
O'Connor PJ, et al. Advances in patient safety clinical inertia and outpatient medical errors, in advances in patient safety: from research to implementation (volume 2: concepts and methodology), K. Henriksen, et al., Editors. Agcy Healthc Res Qual (US): Rockville (MD). 2005.
32.
Allen JD, Curtiss FR, Fairman KA. Nonadherence, clinical inertia, or therapeutic inertia? J Manag Care Pharm. 2009;15(8):690–5.PubMed
33.
Lee JE, et al. Correlates of self-care behaviors for managing hypertension among Korean Americans: a questionnaire survey. Int J Nurs Stud. 2010;47(4):411–7.PubMedCrossRef
34.
35.
Watson RE, Karnchanasorn R, Gossain VV. Hypertension in Asian/Pacific Island Americans. J Clin Hypertens (Greenwich). 2009;11(3):148–52.PubMedCrossRef
36.
Jang SH, et al. Blood pressure monitoring should be a habit: adaptation of the Check. Change. Control. program for Asian American older adults, from group-based in-person to one-on-one telephone delivery. Transl Behav Med. 2021;11(6):1244–1253.
37.
Zhao B, et al. Racial/ethnic differences in hypertension prevalence, treatment, and control for outpatients in northern California 2010–2012. Am J Hypertens. 2015;28(5):631–9.PubMedCrossRef
38.
Taira DA, et al. Antihypertensive Adherence and Drug Class among Asian Pacific Americans. Ethn Health. 2007;12(3):265–81.PubMedCrossRef
39.
Chen M-L, Hu J. Health disparities in Chinese Americans with hypertension: A review. Int J Nurs Sci. 2014;1(3):318–22.
40.
Jung MY, et al. Hypertension Prevalence, Treatment, and Related Behaviors Among Asian Americans: An Examination by Method of Measurement and Disaggregated Subgroups. J Racial Ethn Health Disparities. 2019;6(3):584–93.PubMedPubMedCentralCrossRef
41.
Schaefer KR, et al. Patient and primary care perspectives on hypertension management: short report of a qualitative study in a tribal health system. Int J Circumpolar Health. 2022;81(1):2049054.PubMedPubMedCentralCrossRef
42.
Jolly SE, et al. Prevalence of hypertension and associated risk factors in western Alaska native people: The Western Alaska Tribal Collaborative for Health (WATCH) Study. The Journal of Clinical Hypertension. 2015;17(10):812–8.PubMedPubMedCentralCrossRef
43.
44.
Ramgobin D, et al. Papering over the cracks: COVID-19’s amplification of the failures of employer-based health insurance coverage. J Community Hosp Intern Med Perspect. 2021;11(1):107–10.PubMedPubMedCentralCrossRef
45.
Ruksakulpiwat S, et al. How does the COVID-19 pandemic impact medication adherence of patients with chronic disease? A systematic review, Chronic illness. 2022;17423953221110151.
46.
Kilany M, Rao T, Johnson K, Liu M, Haider T, Barry R, Harris I. No Signs COVID disrupted hypertension medication dherence for Medicare beneficiaries, but racial and ethnic disparities persisted. In American Institutes for Research. 2022.
47.
Omboni S, et al. Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper. Hypertension. 2020;76(5):1368–83.PubMedCrossRef
48.
Shimbo D, et al. Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020;142(4):e42–63.PubMedCrossRef
49.
Adepoju OE, et al. Utilization Gaps During the COVID-19 Pandemic: Racial and Ethnic Disparities in Telemedicine Uptake in Federally Qualified Health Center Clinics. J Gen Intern Med. 2022;37(5):1191–7.PubMedPubMedCentralCrossRef
50.
Eberly LA, et al. Telemedicine Outpatient Cardiovascular Care During the COVID-19 Pandemic: Bridging or Opening the Digital Divide? Circulation. 2020;142(5):510–2.PubMedPubMedCentralCrossRef
51.
Lau D, McAlister FA. Implications of the COVID-19 Pandemic for Cardiovascular Disease and Risk-Factor Management. Can J Cardiol. 2021;37(5):722–32.PubMedCrossRef
52.
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4): e21.PubMedPubMedCentralCrossRef
53.
Thronson LR, Jackson SL, Chew LD. The Pandemic of Health Care Inequity. JAMA Network Open. 2020;3(10):e2021767–e2021767.PubMedCrossRef
54.
Chaudhry SI, et al. Racial disparities in health literacy and access to care among patients with heart failure. J Card Fail. 2011;17(2):122–7.PubMedCrossRef
55.
Bauerly BC, et al. Broadband access as a public health issue: the role of law in expanding broadband access and connecting underserved communities for better health outcomes. J Law Med Ethics. 2019;47(2_suppl):39-42.
56.
Peters M, et al. The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews. 2015.
Metadaten
Titel
The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review
verfasst von
Marva Foster
Anna Etchin
Charlene Pope
Christine W. Hartmann
Oluwabunmi Emidio
Hayden B. Bosworth
Publikationsdatum
25.08.2023
Verlag
Springer US
Erschienen in
Current Hypertension Reports / Ausgabe 11/2023
Print ISSN: 1522-6417
Elektronische ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-023-01262-4

Weitere Artikel der Ausgabe 11/2023

Current Hypertension Reports 11/2023 Zur Ausgabe

Blood Pressure Monitoring and Management (J Cockcroft, Section Editor)

Predicting Changes in Systolic and Diastolic Blood Pressure of Hypertensive Patients in Indonesia Using Machine Learning

Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension

Mechanisms of Hypertension and Target-Organ Damage (JE Hall and ME Hall, Section Editors)

Role of Female Sex Hormones and Immune Response in Salt-Sensitive Hypertension Development: Evidence from Experimental Models

Resistant Hypertension (L Drager, Section Editor)

Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review

Correction

Correction to: Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review

Correction

Correction to: Masked Hypertension in Healthy Children and Adolescents: Who Should Be Screened?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise